{
    "organizations": [],
    "uuid": "9856c43b3b74e78dd9bb5064a9c1a2d14ceae874",
    "author": "",
    "url": "https://www.reuters.com/article/brief-infinity-expects-net-loss-for-2018/brief-infinity-expects-net-loss-for-2018-to-range-from-40-mln-to-50-mln-idUSASB0C04F",
    "ord_in_thread": 0,
    "title": "BRIEF-Infinity Expects Net Loss For 2018 To Range From $40 Mln To $50 Mln​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 8, 2018 / 1:38 PM / Updated 13 minutes ago BRIEF-Infinity Expects Net Loss For 2018 To Range From $40 Mln To $50 Mln​ Reuters Staff 1 Min Read \nJan 8 (Reuters) - Infinity Pharmaceuticals Inc: \n* INFINITY PHARMACEUTICALS INC - ‍INFINITY EXPECTS NET LOSS FOR 2018 TO RANGE FROM $40 MILLION TO $50 MILLION​ \n* INFINITY PROVIDES UPDATE ON IPI-549 PHASE 1/1B STUDY, 2018 GOALS AND FINANCIAL GUIDANCE \n* INFINITY PHARMACEUTICALS INC - ‍INFINITY EXPECTS TO END 2018 WITH A YEAR-END CASH AND INVESTMENTS BALANCE RANGING FROM $10 MILLION TO $20 MILLION​ \n* INFINITY PHARMACEUTICALS INC - EXPECTS TO END 2018 WITH A YEAR-END CASH AND INVESTMENTS BALANCE RANGING FROM $10 MILLION TO $20 MILLION \n* INFINITY PHARMACEUTICALS INC - ‍INFINITY ENDED 2017 WITH APPROXIMATELY $57.6 MILLION IN CASH AND INVESTMENTS​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-08T15:37:00.000+02:00",
    "crawled": "2018-01-08T15:59:09.058+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "expects",
        "net",
        "loss",
        "range",
        "mln",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "infinity",
        "pharmaceutical",
        "inc",
        "infinity",
        "pharmaceutical",
        "inc",
        "expects",
        "net",
        "loss",
        "range",
        "million",
        "infinity",
        "provides",
        "update",
        "phase",
        "study",
        "goal",
        "financial",
        "guidance",
        "infinity",
        "pharmaceutical",
        "inc",
        "expects",
        "end",
        "cash",
        "investment",
        "balance",
        "ranging",
        "million",
        "infinity",
        "pharmaceutical",
        "inc",
        "expects",
        "end",
        "cash",
        "investment",
        "balance",
        "ranging",
        "million",
        "million",
        "infinity",
        "pharmaceutical",
        "inc",
        "ended",
        "approximately",
        "million",
        "cash",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}